Exelixis | Fremdkapital



Loan Capital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
Amgen USD 54.01B 2.54B 2025-03
AstraZeneca USD 27.89B 154M 2025-03
Bayer EUR 35.02B 468M 2025-03
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Cytokinetics USD 645.17M 429K 2025-03
Eisai JPY 99.83B 9M 2025-03
Eli Lilly USD 34.5B 5.97B 2025-03
Exelixis USD 0 0 2025-04
Genmab DKK 129M 808M 2025-03
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Incyte USD 32.64M 899K 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
MacroGenics USD 0 0 2024-12
Merck USD 33.48B 978M 2025-03
Moderna USD 35M 4M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.64B 234M 2025-03
Sanofi 11.79B 712M 2024-12
Takeda JPY 3.97T 738.36B 2025-03
Ultragenyx Pharmaceutical USD 0 0 2024-12
Xencor USD 115.16M 104.99M 2024-12



Exelixis Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.